(Q87287723)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25963090%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25963090%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

main subject

phase III clinical trial

1 reference

Robert S Kerbel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25963090%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Axel Grothey

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25963090%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

12 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25963090%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25963090%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25963090%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25963090%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

313-314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25963090%20AND%20SRC:MED&resulttype=core&format=json

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.89

Metronomic chemotherapy: new rationale for new directions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.89

A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.89

Mouse models of advanced spontaneous metastasis for experimental therapeutics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.89

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.89

Colorectal cancer in 2014: progress in defining first-line and maintenance therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.89

Why do phase III clinical trials in oncology fail so often?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.89

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.89

Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.89

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25963090

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2015.89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25963090%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference